RSL3 is a novel and potent inhibitor of glutathione peroxidase 4 (GPX4), which is able to reduce the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells.